1. Trang chủ
  2. » Tất cả

Đề ôn thi thử môn hóa (89)

6 3 0

Đang tải... (xem toàn văn)

THÔNG TIN TÀI LIỆU

581 Cooperative Study (NAPRTCS) Am J Kidney Dis 2005;45(2) 309–15 22 Tkaczyk M, Nowicki M, Balasz Chmielewska I, Boguszewska Baczkowska H, Drozdz D, Kollataj B, et al Hypertension in dialysed children[.]

30  The Cardiovascular Status of Pediatric Dialysis Patients Cooperative Study (NAPRTCS) Am J Kidney Dis 2005;45(2):309–15 22 Tkaczyk M, Nowicki M, Balasz-Chmielewska I, Boguszewska-Baczkowska H, Drozdz D, Kollataj B, et al Hypertension in dialysed children: the prevalence and therapeutic approach in Poland a nationwide survey Nephrol Dial Transplant 2006;21(3):736–42 23 Mitsnefes MM, Kimball TR, Witt SA, Glascock BJ, Khoury PR, Daniels SR.  Left v­ entricular mass and systolic performance in pediatric patients with chronic renal failure Circulation 2003;107(6):864–8 24 Mitsnefes MM, Daniels SR, Schwartz SM, Meyer RA, Khoury P, Strife CF.  Severe left ventricular hypertrophy in pediatric dialysis: prevalence and predictors Pediatr Nephrol 2000;14(10–11):898–902 25 Litwin M, Wuhl E, Jourdan C, Trelewicz J, Niemirska A, Fahr K, et  al Altered morphologic properties of large arteries in children with chronic renal failure and after renal transplantation J Am Soc Nephrol 2005;16(5):1494–500 26 Wroblewski K, Hincz K, Miklaszewska M, Zachwieja K, Wiercinski R, Stankiewicz R, et  al Antihypertensive treatment prescription in pediatric dialysis patients in Poland: a comparison between two nationwide studies 2003/2004-2013 Adv Clin Exp Med 2017;26(8):1263–8 27 van Stralen KJ, Borzych-Duzalka D, Hataya H, Kennedy SE, Jager KJ, Verrina E, et al Survival and clinical outcomes of children starting renal replacement therapy in the neonatal period Kidney Int 2014;86(1):168–74 28 Chaudhuri A, Sutherland SM, Begin B, Salsbery K, McCabe L, Potter D, et al Role of twenty-four-hour ambulatory blood pressure monitoring in children on dialysis Clin J Am Soc Nephrol 2011;6(4):870–6 29 VanDeVoorde RG, Barletta GM, Chand DH, Dresner IG, Lane J, Leiser J, et  al Blood pressure control in pediatric hemodialysis: the Midwest Pediatric Nephrology Consortium Study Pediatr Nephrol 2007;22(4):547–53 30 Fischbach M, Terzic J, Menouer S, Dheu C, Seuge L, Zalosczic A. Daily on line haemodiafiltration promotes catch-up growth in children on chronic dialysis Nephrol Dial Transplant 2010;25(3):867–73 31 Mitsnefes MM, Barletta GM, Dresner IG, Chand DH, Geary D, Lin JJ, et al Severe cardiac hypertrophy and long-term dialysis: the Midwest Pediatric Nephrology Consortium study Pediatr Nephrol 2006;21(8):1167–70 32 Ulinski T, Genty J, Viau C, Tillous-Borde I, Deschenes G. Reduction of left ventricular hypertrophy in children undergoing hemodialysis Pediatr Nephrol 2006;21(8):1171–8 33 Lee JH, Park YS. The B-type natriuretic peptide is a useful biomarker for the estimation of volume overload in children with hypertension in children on peritoneal dialysis Nephrology (Carlton) 2018;24:341 34 Muntner P, Coresh J, Smith JC, Eckfeldt J, Klag MJ.  Plasma lipids and risk of developing renal dys- 581 function: the atherosclerosis risk in communities study Kidney Int 2000;58(1):293–301 35 Saland JM, Pierce CB, Mitsnefes MM, Flynn JT, Goebel J, Kupferman JC, et  al Dyslipidemia in children with chronic kidney disease Kidney Int 2010;78(11):1154–63 36 Cheng SC, Chu TS, Huang KY, Chen YM, Chang WK, Tsai TJ, et al Association of hypertriglyceridemia and insulin resistance in uremic patients undergoing CAPD. Perit Dial Int: journal of the International Society for Peritoneal Dialysis 2001;21(3):282–9 37 Mak RH 1,25-Dihydroxyvitamin D3 corrects insulin and lipid abnormalities in uremia Kidney Int 1998;53(5):1353–7 38 Mak RH. Effect of metabolic acidosis on hyperlipidemia in uremia Pediatr Nephrol 1999;13(9):891–3 39 Chan PC, Persaud J, Varghese Z, Kingstone D, Baillod RA, Moorhead JF. Apolipoprotein B turnover in dialysis patients: its relationship to pathogenesis of hyperlipidemia Clin Nephrol 1989;31(2):88–95 40 Horkko S, Huttunen K, Kesaniemi YA.  Decreased clearance of low-density lipoprotein in uremic patients under dialysis treatment Kidney Int 1995;47(6):1732–40 41 Saland JM, Ginsberg H, Fisher EA.  Dyslipidemia in pediatric renal disease: epidemiology, pathophysiology, and management Curr Opin Pediatr 2002;14(2):197–204 42 Wang X, Axelsson J, Nordfors L, Qureshi AR, Avesani C, Barany P, et al Changes in fat mass after initiation of maintenance dialysis is influenced by the uncoupling protein exon insertion/deletion polymorphism Nephrol Dial Transplant 2007;22(1):196–202 43 Kalantar-Zadeh K, Kopple JD.  Relative contri butions of nutrition and inflammation to clinical outcome in dialysis patients Am J Kidney Dis 2001;38(6):1343–50 44 Kalantar-Zadeh K, Block G, Humphreys MH, Kopple JD.  Reverse epidemiology of cardiovascular risk factors in maintenance dialysis patients Kidney Int 2003;63(3):793–808 45 Block GA, Hulbert-Shearon TE, Levin NW, Port FK.  Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study Am J Kidney Dis 1998;31(4):607–17 46 Prie D, Urena Torres P, Friedlander G.  Latest findings in phosphate homeostasis Kidney Int 2009;75(9):882–9 47 Kestenbaum B, Sampson JN, Rudser KD, Patterson DJ, Seliger SL, Young B, et al Serum phosphate levels and mortality risk among people with chronic kidney disease J Am Soc Nephrol 2005;16(2):520–8 48 Voormolen N, Noordzij M, Grootendorst DC, Beetz I, Sijpkens YW, van Manen JG, et  al High plasma phosphate as a risk factor for decline in renal function and mortality in pre-dialysis patients Nephrol Dial Transplant 2007;22(10):2909–16 582 49 Giachelli CM.  Vascular calcification: in  vitro evi dence for the role of inorganic phosphate J Am Soc Nephrol 2003;14(9 Suppl 4):S300–4 50 Shroff RC, Shanahan CM.  The vascular biology of calcification Semin Dial 2007;20(2):103–9 51 Block GA, Kilpatrick RD, Lowe KA, Wang W, Danese MD.  CKD-mineral and bone disorder and risk of death and cardiovascular hospitalization in patients on hemodialysis Clin J Am Soc Nephrol 2013;8(12):2132–40 52 Ketteler M, Block GA, Evenepoel P, Fukagawa M, Herzog CA, McCann L, et  al Diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder: synopsis of the kidney disease: improving global outcomes 2017 clinical practice guideline update Ann Intern Med 2018;168(6):422–30 53 Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-­ Mineral and Bone Disorder (CKD-MBD) Kidney Int Suppl 2009:S1–130 54 Sigrist MK, McIntyre CW.  Vascular calcification is associated with impaired microcirculatory function in chronic haemodialysis patients Nephron Clin Pract 2008;108(2):c121–6 55 London GM, Marty C, Marchais SJ, Guerin AP, Metivier F, de Vernejoul MC.  Arterial calcifications and bone histomorphometry in end-stage renal disease J Am Soc Nephrol 2004;15(7):1943–51 56 Chertow GM, Burke SK, Raggi P. Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients Kidney Int 2002;62(1):245–52 57 Himmelfarb J, Stenvinkel P, Ikizler TA, Hakim RM. The elephant in uremia: oxidant stress as a unifying concept of cardiovascular disease in uremia Kidney Int 2002;62(5):1524–38 58 Wanner C, Zimmermann J, Schwedler S, Metzger T.  Inflammation and cardiovascular risk in dialysis patients Kidney Int Suppl 2002;80:99–102 59 Herzig KA, Purdie DM, Chang W, Brown AM, Hawley CM, Campbell SB, et al Is C-reactive protein a useful predictor of outcome in peritoneal dialysis patients? J Am Soc Nephrol 2001;12(4):814–21 60 Bakkaloglu SA, Saygili A, Sever L, Noyan A, Akman S, Ekim M, et  al Assessment of cardiovascular risk in paediatric peritoneal dialysis patients: a Turkish Pediatric Peritoneal Dialysis Study Group (TUPEPD) report Nephrol Dial Transplant 2009;24(11):3525–32 61 Aguilera A, Sanchez-Tomero JA, Bajo MA, Ruiz-Caravaca ML, Alvarez V, del Peso G, et  al Malnutrition-inflammation syndrome is associated with endothelial dysfunction in peritoneal dialysis patients Adv Perit Dial 2003;19:240–5 62 Pecoits-Filho R, Sylvestre LC, Stenvinkel P. Chronic kidney disease and inflammation in pediatric R Shroff and M M Mitsnefes patients: from bench to playground Pediatr Nephrol 2005;20(6):714–20 63 Ketteler M, Wanner C, Metzger T, Bongartz P, Westenfeld R, Gladziwa U, et  al Deficiencies of calcium-­ regulatory proteins in dialysis patients: a novel concept of cardiovascular calcification in uremia Kidney Int Suppl 2003;84:S84–7 64 Wang AY, Woo J, Lam CW, Wang M, Chan IH, Gao P, et  al Associations of serum fetuin-A with malnutrition, inflammation, atherosclerosis and valvular calcification syndrome and outcome in peritoneal dialysis patients Nephrol Dial Transplant 2005;20(8):1676–85 65 Levin A, Li YC.  Vitamin D and its analogues: they protect against cardiovascular disease in patients with kidney disease? Kidney Int 2005;68(5):1973–81 66 Shroff R, Egerton M, Bridel M, Shah V, Donald AE, Cole TJ, et al A bimodal association of vitamin D levels and vascular disease in children on dialysis J Am Soc Nephrol 2008;19(6):1239–46 67 Sasaki T, Watanabe M, Nagai Y, Hoshi T, Takasawa M, Nukata M, et al Association of plasma homocysteine concentration with atherosclerotic carotid plaques and lacunar infarction Stroke 2002;33(6):1493–6 68 Taruangsri P, Ong-Ajyooth L, Ong-Ajyooth S, Chaiyasoot W, Leowattana W, Sritippayawan S, et al Relationship between hyperhomocysteinemia and atherosclerosis in chronic hemodialysis patients J Med Assoc Thail 2005;88(10):1373–81 69 Civilibal M, Caliskan S, Oflaz H, Sever L, Candan C, Canpolat N, et  al Traditional and "new" cardiovascular risk markers and factors in pediatric dialysis patients Pediatr Nephrol 2007;22(7):1021–9 70 Bennett-Richards K, Kattenhorn M, Donald A, Oakley G, Varghese Z, Rees L, et al Does oral folic acid lower total homocysteine levels and improve endothelial function in children with chronic renal failure? Circulation 2002;105(15):1810–5 71 Ebbing M, Bonaa KH, Nygard O, Arnesen E, Ueland PM, Nordrehaug JE, et al Cancer incidence and mortality after treatment with folic acid and vitamin B12 JAMA 2009;302(19):2119–26 72 Fadrowski JJ, Pierce CB, Cole SR, Moxey-Mims M, Warady BA, Furth SL. Hemoglobin decline in children with chronic kidney disease: baseline results from the chronic kidney disease in children prospective cohort study Clin J Am Soc Nephrol 2008;3(2):457–62 73 Staples AO, Wong CS, Smith JM, Gipson DS, Filler G, Warady BA, et al Anemia and risk of hospitalization in pediatric chronic kidney disease Clin J Am Soc Nephrol 2009;4(1):48–56 74 Warady BA, Ho M. Morbidity and mortality in children with anemia at initiation of dialysis Pediatr Nephrol 2003;18(10):1055–62 75 Feber J, Wong H, Geier P, Chaudry B, Filler G.  Complications of chronic kidney disease in children post-renal transplantation - a single center experience Pediatr Transplant 2008;12(1):80–4 30  The Cardiovascular Status of Pediatric Dialysis Patients 76 Borzych-Duzalka D, Bilginer Y, Ha IS, Bak M, Rees L, Cano F, et  al Management of anemia in children receiving chronic peritoneal dialysis J Am Soc Nephrol 2013;24(4):665–76 77 White CT, Schisler T, Er L, Djurdjev O, Matsuda-­ Abedini M.  CKD following kidney transplantation in children and adolescents Am J Kidney Dis 2008;51(6):996–1004 78 Shroff RC, Donald AE, Hiorns MP, Watson A, Feather S, Milford D, et al Mineral metabolism and vascular damage in children on dialysis J Am Soc Nephrol 2007;18(11):2996–3003 79 Querfeld U, Schaefer F.  Cardiovascular risk factors in children on dialysis: an update Pediatr Nephrol 2018;35:41 80 Teng M, Wolf M, Lowrie E, Ofsthun N, Lazarus JM, Thadhani R. Survival of patients undergoing hemodialysis with paricalcitol or calcitriol therapy N Engl J Med 2003;349(5):446–56 81 Tentori F, Hunt WC, Stidley CA, Rohrscheib MR, Bedrick EJ, Meyer KB, et  al Mortality risk among hemodialysis patients receiving different vitamin D analogs Kidney Int 2006;70(10):1858–65 82 Wolf M, Shah A, Gutierrez O, Ankers E, Monroy M, Tamez H, et  al Vitamin D levels and early mortality among incident hemodialysis patients Kidney Int 2007;72(8):1004–13 83 Gutierrez OM, Mannstadt M, Isakova T, Rauh-Hain JA, Tamez H, Shah A, et al Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis N Engl J Med 2008;359(6):584–92 84 Shroff RC, Shah V, Hiorns MP, Schoppet M, Hofbauer LC, Hawa G, et al The circulating calcification inhibitors, fetuin-A and osteoprotegerin, but not matrix Gla protein, are associated with vascular stiffness and calcification in children on dialysis Nephrol Dial Transplant 2008;23(10):3263–71 85 Kanderian AS, Francis GS.  Cardiac troponins and chronic kidney disease Kidney Int 2006;69(7):1112–4 86 Johnstone LM, Jones CL, Grigg LE, Wilkinson JL, Walker RG, Powell HR.  Left ventricular abnormalities in children, adolescents and young adults with renal disease Kidney Int 1996;50(3):998–1006 87 Matteucci MC, Wuhl E, Picca S, Mastrostefano A, Rinelli G, Romano C, et  al Left ventricular geometry in children with mild to moderate chronic renal insufficiency J Am Soc Nephrol 2006;17(1):218–26 88 Bakkaloglu SA, Kandur Y, Serdaroglu E, Noyan A, Bayazit AK, Sever L, et  al Effect of the timing of dialysis initiation on left ventricular hypertrophy and inflammation in pediatric patients Pediatr Nephrol 2017;32(9):1595–602 89 Bakkaloglu SA, Borzych D, Soo Ha I, Serdaroglu E, Buscher R, Salas P, et  al Cardiac geometry in children receiving chronic peritoneal dialysis: findings from the International Pediatric Peritoneal Dialysis Network (IPPN) registry Clin J Am Soc Nephrol 2011;6(8):1926–33 583 90 Goren A, Glaser J, Drukker A. Diastolic function in children and adolescents on dialysis and after kidney transplantation: an echocardiographic assessment Pediatr Nephrol 1993;7(6):725–8 91 Morris KP, Skinner JR, Wren C, Hunter S, Coulthard MG.  Cardiac abnormalities in end stage renal failure and anaemia Arch Dis Child 1993;68(5):637–43 92 Mitsnefes MM, Kimball TR, Border WL, Witt SA, Glascock BJ, Khoury PR, et al Impaired left ventricular diastolic function in children with chronic renal failure Kidney Int 2004;65(4):1461–6 93 Mitsnefes MM, Kimball TR, Border WL, Witt SA, Glascock BJ, Khoury PR, et  al Abnormal cardiac function in children after renal transplantation Am J Kidney Dis 2004;43(4):721–6 94 Saygili A, Yildirim SV, Cengiz N, Uslu Y, Tokel K, Saatci U.  Assessment of left ventricular diastolic function by Doppler tissue imaging in children with end-stage renal disease Acta Paediatr 2005;94(8):1055–9 95 Weaver DJ Jr, Kimball TR, Knilans T, Mays W, Knecht SK, Gerdes YM, et  al Decreased maximal aerobic capacity in pediatric chronic kidney disease J Am Soc Nephrol 2008;19(3):624–30 96 Chinali M, de Simone G, Matteucci MC, Picca S, Mastrostefano A, Anarat A, et al Reduced systolic myocardial function in children with chronic renal insufficiency J Am Soc Nephrol 2007;18(2):593–8 97 Mignot A, Donal E, Zaroui A, Reant P, Salem A, Hamon C, et al Global longitudinal strain as a major predictor of cardiac events in patients with depressed left ventricular function: a multicenter study J Am Soc Echocardiogr 2010;23(10):1019–24 98 Kramann R, Erpenbeck J, Schneider RK, Rohl AB, Hein M, Brandenburg VM, et  al Speckle tracking echocardiography detects uremic cardiomyopathy early and predicts cardiovascular mortality in ESRD. J Am Soc Nephrol 2014;25(10):2351–65 99 Chinali M, Matteucci MC, Franceschini A, Doyon A, Pongiglione G, Rinelli G, et al Advanced parameters of cardiac mechanics in children with CKD: the 4C study Clin J Am Soc Nephrol 2015;10(8):1357–63 100 Rumman RK, Slorach C, Hui W, Matsuda-­ Abedini M, Langlois V, Radhakrishnan S, et  al Cardiovascular structure and function in children with middle aortic syndrome and renal artery stenosis Hypertension 2017;70(6):1193–200 101 Rumman RK, Ramroop R, Chanchlani R, Ghany M, Hebert D, Harvey EA, et al Longitudinal assessment of myocardial function in childhood chronic kidney disease, during dialysis, and following kidney transplantation Pediatr Nephrol 2017;32(8):1401–10 102 Malatesta-Muncher R, Wansapura J, Taylor M, Lindquist D, Hor K, Mitsnefes M.  Early cardiac dysfunction in pediatric patients on maintenance dialysis and post kidney transplant Pediatr Nephrol 2012;27(7):1157–64 103 Hothi DK, Rees L, Marek J, Burton J, McIntyre CW. Pediatric myocardial stunning underscores the 584 R Shroff and M M Mitsnefes chronic hemodialysis Hemodial Int Int Symp Home cardiac toxicity of conventional hemodialysis treatHemodial 2010;14(3):263–9 ments Clin J Am Soc Nephrol 2009;4(4):790–7 104 Goodman WG, Goldin J, Kuizon BD, Yoon C, 117 Chen J, Budoff MJ, Reilly MP, Yang W, Rosas SE, Rahman M, et al Coronary artery calcification and Gales B, Sider D, et  al Coronary-artery calcifirisk of cardiovascular disease and death among cation in young adults with end-stage renal dispatients with chronic kidney disease JAMA Cardiol ease who are undergoing dialysis N Engl J Med 2017;2(6):635–43 2000;342(20):1478–83 105 Eifinger F, Wahn F, Querfeld U, Pollok M, Gevargez 118 Xie Q, Ge X, Shang D, Li Y, Yan H, Tian J, et  al Coronary artery calcification score as a predictor of A, Kriener P, et  al Coronary artery calcifications all-cause mortality and cardiovascular outcome in in children and young adults treated with renal peritoneal dialysis patients Perit Dial Int: journal replacement therapy Nephrol Dial Transplant of the International Society for Peritoneal Dialysis 2000;15(11):1892–4 2016;36(2):163–70 106 Groothoff JW, Gruppen MP, Offringa M, de Groot E, 119 Krmar RT, Balzano R, Jogestrand T, Cedazo-­ Stok W, Bos WJ, et al Increased arterial stiffness in Minguez A, Englund MS, Berg UB.  Prospective young adults with end-stage renal disease since childanalysis of carotid arterial wall structure in pedihood J Am Soc Nephrol 2002;13(12):2953–61 atric renal transplants with ambulatory normoten 107 Mitsnefes MM, Kimball TR, Kartal J, Witt SA, sion and in treated hypertensive recipients Pediatr Glascock BJ, Khoury PR, et al Cardiac and vascular Transplant 2008;12(4):412–9 adaptation in pediatric patients with chronic kidney disease: role of calcium-phosphorus metabolism J 120 Mitsnefes MM. Understanding carotid artery intima-­ media thickness in childhood: lessons from studies Am Soc Nephrol 2005;16(9):2796–803 in children with renal transplants Pediatr Transplant 108 Covic A, Mardare N, Gusbeth-Tatomir P, Brumaru 2008;12(4):377–80 O, Gavrilovici C, Munteanu M, et al Increased arterial stiffness in children on haemodialysis Nephrol 121 Shroff RC, McNair R, Figg N, Skepper JN, Schurgers L, Gupta A, et al Dialysis accelerates medial vascuDial Transplant 2006;21(3):729–35 lar calcification in part by triggering smooth muscle 109 Briese S, Wiesner S, Will JC, Lembcke A, Opgen-­ cell apoptosis Circulation 2008;118(17):1748–57 Rhein B, Nissel R, et al Arterial and cardiac disease in young adults with childhood-onset end-stage 122 Reynolds JL, Skepper JN, McNair R, Kasama T, Gupta K, Weissberg PL, et al Multifunctional roles renal disease-impact of calcium and vitamin D therfor serum protein fetuin-a in inhibition of human apy Nephrol Dial Transplant 2006;21(7):1906–14 vascular smooth muscle cell calcification J Am Soc 110 Civilibal M, Caliskan S, Adaletli I, Oflaz H, Sever Nephrol 2005;16(10):2920–30 L, Candan C, et  al Coronary artery calcifications in children with end-stage renal disease Pediatr 123 van Summeren MJ, Hameleers JM, Schurgers LJ, Hoeks AP, Uiterwaal CS, Kruger T, et al Circulating Nephrol 2006;21(10):1426–33 calcification inhibitors and vascular properties in 111 Poyrazoglu HM, Dusunsel R, Yikilmaz A, Narin N, children after renal transplantation Pediatr Nephrol Anarat R, Gunduz Z, et al Carotid artery thickness 2008;23(6):985–93 in children and young adults with end stage renal 124 Schurgers LJ, Teunissen KJ, Knapen MH, disease Pediatr Nephrol 2007;22(1):109–16 Kwaijtaal M, van Diest R, Appels A, et  al Novel 112 Srivaths PR, Goldstein SL, Krishnamurthy R, conformation-specific antibodies against matrix Silverstein DM.  High serum phosphorus and gamma-carboxyglutamic acid (Gla) protein: underFGF 23 levels are associated with progrescarboxylated matrix Gla protein as marker for vassion of coronary calcifications Pediatr Nephrol cular calcification Arterioscler Thromb Vasc Biol 2014;29(1):103–9 2005;25(8):1629–33 113 Litwin M, Wuhl E, Jourdan C, Niemirska A, Schenk JP, Jobs K, et al Evolution of large-vessel arteriopa- 125 Smith ER, Ford ML, Tomlinson LA, Bodenham E, McMahon LP, Farese S, et  al Serum calcification thy in paediatric patients with chronic kidney dispropensity predicts all-cause mortality in predialysis ease Nephrol Dial Transplant 2008;23(8):2552–7 CKD. J Am Soc Nephrol 2014;25(2):339–48 114 Brady TM, Schneider MF, Flynn JT, Cox C, Samuels J, Saland J, et al Carotid intima-media thickness in 126 Pasch A, Block GA, Bachtler M, Smith ER, Jahnen-­ Dechent W, Arampatzis S, et  al Blood calcificachildren with CKD: results from the CKiD study tion propensity, cardiovascular events, and survival Clin J Am Soc Nephrol 2012;7(12):1930–7 in patients receiving hemodialysis in the EVOLVE 115 Srivaths PR, Goldstein SL, Silverstein DM, trial Clin J Am Soc Nephrol 2017;12(2):315–22 Krishnamurthy R, Brewer ED.  Elevated FGF 23 127 Scialla JJ, Kao WH, Crainiceanu C, Sozio SM, and phosphorus are associated with coronary calci- Oberai PC, Shafi T, et al Biomarkers of vascular calfication in hemodialysis patients Pediatr Nephrol cification and mortality in patients with ESRD. Clin 2011;26(6):945–51 J Am Soc Nephrol 2014;9(4):745–55 116 Srivaths PR, Silverstein DM, Leung J, Krishnamurthy R, Goldstein SL.  Malnutrition-inflammation-­ 128 Holick MF.  Vitamin D deficiency N Engl J Med 2007;357(3):266–81 coronary calcification in pediatric patients receiving 30  The Cardiovascular Status of Pediatric Dialysis Patients 129 Levin A, Bakris GL, Molitch M, Smulders M, Tian J, Williams LA, et al Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease Kidney Int 2007;71(1):31–8 130 Rostand SG, Drueke TB. Parathyroid hormone, vitamin D, and cardiovascular disease in chronic renal failure Kidney Int 1999;56(2):383–92 131 Doyon A, Schmiedchen B, Sander A, Bayazit A, Duzova A, Canpolat N, et al Genetic, environmental, and disease-associated correlates of vitamin D status in children with CKD. Clin J Am Soc Nephrol 2016;11(7):1145–53 132 Shroff R, Wan M, Nagler EV, Bakkaloglu S, Cozzolino M, Bacchetta J, et  al Clinical practice recommendations for treatment with active vitamin D analogues in children with chronic kidney disease stages 2-5 and on dialysis Nephrol Dial Transplant 2017;32(7):1114–27 133 Shroff R, Wan M, Nagler EV, Bakkaloglu S, Fischer DC, Bishop N, et al Clinical practice recommendations for native vitamin D therapy in children with chronic kidney disease stages 2-5 and on dialysis Nephrol Dial Transplant 2017;32(7):1098–113 134 Li YC, Kong J, Wei M, Chen ZF, Liu SQ, Cao LP 1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system J Clin Invest 2002;110(2):229–38 135 Bodyak N, Ayus JC, Achinger S, Shivalingappa V, Ke Q, Chen YS, et  al Activated vitamin D attenuates left ventricular abnormalities induced by dietary sodium in Dahl salt-sensitive animals Proc Natl Acad Sci U S A 2007;104(43):16810–5 136 Zittermann A, Schleithoff SS, Koerfer R.  Putting cardiovascular disease and vitamin D insufficiency into perspective Br J Nutr 2005;94(4):483–92 137 Schoppet M, Shroff RC, Hofbauer LC, Shanahan CM.  Exploring the biology of vascular calcification in chronic kidney disease: what's circulating? Kidney Int 2008;73(4):384–90 138 Shroff RC, McNair R, Skepper JN, Figg N, Schurgers LJ, Deanfield J, et  al Chronic mineral dysregulation promotes vascular smooth muscle cell adaptation and extracellular matrix calcification J Am Soc Nephrol 2010;21(1):103–12 139 Liu Y, Drozdov I, Shroff R, Beltran LE, Shanahan CM.  Prelamin A accelerates vascular calcification via activation of the DNA damage response and senescence-associated secretory phenotype in vascular smooth muscle cells Circ Res 2013;112(10):e99–109 140 Olive M, Harten I, Mitchell R, Beers JK, Djabali K, Cao K, et  al Cardiovascular pathology in Hutchinson-Gilford progeria: correlation with the vascular pathology of aging Arterioscler Thromb Vasc Biol 2010;30(11):2301–9 141 Gerhard-Herman M, Smoot LB, Wake N, Kieran MW, Kleinman ME, Miller DT, et  al Mechanisms of premature vascular aging in chil- 585 dren with Hutchinson-Gilford progeria syndrome Hypertension 2012;59(1):92–7 142 Sanchis P HC, Liu Y, Beltran LE, Ahmad S, Jacob AP, Furmanik M, Laycock J, Long DA, Shroff R, Shanahan CM.  Arterial ‘inflammaging’ drives vascular calcification in children on dialysis Kidney International Accepted for publication 2019 143 Malluche HH, Blomquist G, Monier-Faugere MC, Cantor TL, Davenport DL.  High parathyroid hormone level and osteoporosis predict progression of coronary artery calcification in patients on dialysis J Am Soc Nephrol 2015;26(10):2534–44 144 Cejka D, Weber M, Diarra D, Reiter T, Kainberger F, Haas M. Inverse association between bone microarchitecture assessed by HR-pQCT and coronary artery calcification in patients with end-stage renal disease Bone 2014;64:33–8 145 Moe S, Drueke T, Cunningham J, Goodman W, Martin K, Olgaard K, et  al Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO) Kidney Int 2006;69(11):1945–53 146 Bell L, Espinosa P.  Intensive in-center hemodialysis for children: a case for longer dialysis duration Hemodial Int Int Symp Home Hemodial 2003;7(4):290–5 147 Goldstein SL, Silverstein DM, Leung JC, Feig DI, Soletsky B, Knight C, et al Frequent hemodialysis with NxStage system in pediatric patients receiving maintenance hemodialysis Pediatr Nephrol 2008;23(1):129–35 148 Warady BA, Fischbach M, Geary D, Goldstein SL. Frequent hemodialysis in children Adv Chronic Kidney Dis 2007;14(3):297–303 149 Maduell F, Navarro V, Torregrosa E, Rius A, Dicenta F, Cruz MC, et al Change from three times a week on-line hemodiafiltration to short daily on-line hemodiafiltration Kidney Int 2003;64(1):305–13 150 Punal J, Lema LV, Sanhez-Guisande D, Ruano-­ Ravina A.  Clinical effectiveness and quality of life of conventional haemodialysis versus short daily haemodialysis: a systematic review Nephrol Dial Transplant 2008;23(8):2634–46 151 Coyte PC, Young LG, Tipper BL, Mitchell VM, Stoffman PR, Willumsen J, et al An economic evaluation of hospital-based hemodialysis and home-­ based peritoneal dialysis for pediatric patients Am J Kidney Dis 1996;27(4):557–65 152 McFarlane PA, Bayoumi AM, Pierratos A, Redelmeier DA.  The impact of home nocturnal hemodialysis on end-stage renal disease therapies: a decision analysis Kidney Int 2006;69(5):798–805 153 Geary DF, Piva E, Tyrrell J, Gajaria MJ, Picone G, Keating LE, et al Home nocturnal hemodialysis in children J Pediatr 2005;147(3):383–7 154 Blankestijn PJ, Ledebo I, Canaud B. Hemodiafiltration: clinical evidence and remaining questions Kidney Int 2010;77(7):581–7 586 155 Ledebo I, Blankestijn PJ. Haemodiafiltration-optimal efficiency and safety NDT Plus 2010;3(1):8–16 156 Mostovaya IM, Grooteman MP, Basile C, Davenport A, de Roij van Zuijdewijn CL, Wanner C, et al High convection volume in online post-dilution haemodiafiltration: relevance, safety and costs Clin Kidney J 2015;8(4):368–73 157 Maduell F, Moreso F, Pons M, Ramos R, Mora-­ Macia J, Carreras J, et  al High-efficiency postdilution online hemodiafiltration reduces all-cause mortality in hemodialysis patients J Am Soc Nephrol 2013;24(3):487–97 158 Ok E, Asci G, Toz H, Ok ES, Kircelli F, Yilmaz M, et al Mortality and cardiovascular events in online haemodiafiltration (OL-HDF) compared with high-­ flux dialysis: results from the Turkish OL-HDF Study Nephrol Dial Transplant 2013;28(1):192–202 159 Peters SA, Bots ML, Canaud B, Davenport A, Grooteman MP, Kircelli F, et al Haemodiafiltration and mortality in end-stage kidney disease patients: a pooled individual participant data analysis from four randomized controlled trials Nephrol Dial Transplant 2016;31(6):978–84 160 Fadel FI, Makar SH, Zekri H, Ahmed DH, Aon AH.  The effect of on-line hemodiafiltration on improving the cardiovascular function parameters in children on regular dialysis Saudi J Kidney Dis Transpl 2015;26(1):39–46 161 Morad AA, Bazaraa HM, Abdel Aziz RE, Abdel Halim DA, Shoman MG, Saleh ME. Role of online hemodiafiltration in improvement of inflammatory status in pediatric patients with end-stage renal disease Iran J Kidney Dis 2014;8(6):481–5 162 Shroff R, Bayazit A, Stefanidis CJ, Askiti V, Azukaitis K, Canpolat N, et al Effect of haemodiafiltration vs conventional haemodialysis on growth and cardiovascular outcomes in children  - the HDF, heart and height (3H) study BMC Nephrol 2018;19(1):199 163 Agbas A, Canpolat N, Caliskan S, Yilmaz A, Ekmekci H, Mayes M, et  al Hemodiafiltration is associated with reduced inflammation, oxidative stress and improved endothelial risk profile compared to high-flux hemodialysis in children PLoS One 2018;13(6):e0198320 164 Hothi DK, Stronach L, Sinnott K.  Home hemodialysis in children Hemodial Int Int Symp Home Hemodial 2016;20(3):349–57 165 Hothi DK, Harvey E, Piva E, Keating L, Secker D, Geary DF.  Calcium and phosphate balance in adolescents on home nocturnal haemodialysis Pediatr Nephrol 2006;21(6):835–41 166 de Camargo MF, Henriques CL, Vieira S, Komi S, Leao ER, Nogueira PC.  Growth of children with end-stage renal disease undergoing daily hemodialysis Pediatr Nephrol 2014;29(3):439–44 167 Hoppe A, von Puttkamer C, Linke U, Kahler C, Booss M, Braunauer-Kolberg R, et  al A hospital-­ based intermittent nocturnal hemodialysis pro- R Shroff and M M Mitsnefes gram for children and adolescents J Pediatr 2011;158(1):95–9, e1 168 Thumfart J, Muller D, Wagner S, Jayanti A, Borzych-­ Duzalka D, Schaefer F, et al Barriers for implementation of intensified hemodialysis: survey results from the International Pediatric Dialysis Network Pediatr Nephrol 2018;33(4):705–12 169 Wuhl E, Fusch C, Scharer K, Mehls O, Schaefer F.  Assessment of total body water in paediatric patients on dialysis Nephrol Dial Transplant 1996;11(1):75–80 170 Krause I, Birk E, Davidovits M, Cleper R, Blieden L, Pinhas L, et  al Inferior vena cava diameter: a useful method for estimation of fluid status in children on haemodialysis Nephrol Dial Transplant 2001;16(6):1203–6 171 Katzarski KS, Charra B, Luik AJ, Nisell J, Divino Filho JC, Leypoldt JK, et  al Fluid state and blood pressure control in patients treated with long and short haemodialysis Nephrol Dial Transplant 1999;14(2):369–75 172 Muller D, Zimmering M, Chan CT, McFarlane PA, Pierratos A, Querfeld U.  Intensified hemodialysis regimens: neglected treatment options for children and adolescents Pediatr Nephrol 2008;23(10):1729–36 173 Thumfart J, Puttkamer CV, Wagner S, Querfeld U, Muller D.  Hemodiafiltration in a pediatric nocturnal dialysis program Pediatr Nephrol 2014;29(8):1411–6 174 K/DOQI clinical practice guidelines for cardiovascular disease in dialysis patients Am J Kidney Dis 2005;45(4 Suppl 3):S1–153 175 Khoury PR, Mitsnefes M, Daniels SR, Kimball TR. Age-specific reference intervals for indexed left ventricular mass in children J Am Soc Echocardiogr 2009;22(6):709–14 176 Foster BJ, Mackie AS, Mitsnefes M, Ali H, Mamber S, Colan SD.  A novel method of expressing left ventricular mass relative to body size in children Circulation 2008;117(21):2769–75 177 Borzych D, Bakkaloglu SA, Zaritsky J, Suarez A, Wong W, Ranchin B, et al Defining left ventricular hypertrophy in children on peritoneal dialysis Clin J Am Soc Nephrol 2011;6(8):1934–43 178 Flynn JT, Kaelber DC, Baker-Smith CM, Blowey D, Carroll AE, Daniels SR, et  al Clinical practice guideline for screening and management of high blood pressure in children and adolescents Pediatrics 2017;140(3):e20171904 179 Chinali M, Emma F, Esposito C, Rinelli G, Franceschini A, Doyon A, et  al Left ventricular mass indexing in infants, children, and adolescents: a simplified approach for the identification of left ventricular hypertrophy in clinical practice J Pediatr 2016;170:193–8 180 K/DOQI Clinical practice guidelines for bone metabolism and disease in chronic kidney disease Am J Kidney Dis 2004;42(4, Suppl 3):S1–S201 ... PLoS One 2018;13(6):e0198320 164 Hothi DK, Stronach L, Sinnott K.  Home hemodialysis in children Hemodial Int Int Symp Home Hemodial 2016;20(3):349–57 165 Hothi DK, Harvey E, Piva E, Keating L,... of calcium-phosphorus metabolism J 120 Mitsnefes MM. Understanding carotid artery intima-­ media thickness in childhood: lessons from studies Am Soc Nephrol 2005;16(9):2796–803 in children with... N, children after renal transplantation Pediatr Nephrol Anarat R, Gunduz Z, et al Carotid artery thickness 2008;23(6):985–93 in children and young adults with end stage renal 124 Schurgers LJ,

Ngày đăng: 28/03/2023, 11:23

Xem thêm:

w